Overview

  • Product nameBromocriptine mesylate
  • Description
    Potent, selective D2-like dopamine receptor agonist
  • Biological descriptionPotent, selective D2-like dopamine receptor agonist (Ki values are ~8 (D2), ~5 (D3), ~290 (D4), ~440 (D1) and ~450 nM (D5)). Inhibits the release of pituitary prolactin and stimulates motor activity in Parkinson's disease. Also reverses glutamate transporter 1 (GLT-1) activity, increasing glutamate levels.
  • Purity> 99%

Properties

    References for Bromocriptine mesylate (ab120574)

    This product has been referenced in:
    • Shirasaki Y  et al. Bromocriptine, an ergot alkaloid, inhibits excitatory amino acid release mediated by glutamate transporter reversal. Eur J Pharmacol 643:48-57 (2010). Read more (PubMed: 20599932) »
    • Lindgren HS  et al. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease. Neuropsychopharmacology 34:2477-88 (2009). Read more (PubMed: 19606087) »
    • Valente D  et al. Metabolite involvement in bromocriptine-induced prolactin inhibition in rats. J Pharmacol Exp Ther 282:1418-24 (1997). Read more (PubMed: 9316855) »
    • Seeman P & Van Tol HH Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-70 (1994). Read more (PubMed: 7940991) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120574.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"